Orchestra BioMed
OBIO
OBIO
46 hedge funds and large institutions have $130M invested in Orchestra BioMed in 2021 Q1 according to their latest regulatory filings, with 7 funds opening new positions, 7 increasing their positions, 4 reducing their positions, and 7 closing their positions.
Holders
46
Holders Change
–
Holders Change %
0%
% of All Funds
0.81%
Holding in Top 10
1
Holding in Top 10 Change
+1
Holding in Top 10 Change %
%
% of All Funds
0.02%
New
7
Increased
7
Reduced
4
Closed
7
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–
Top Buyers
1 |
AC
1
Amitell Capital
Singapore
|
$5.36M |
2 |
IC
2
Ikarian Capital
Dallas,
Texas
|
$2.25M |
3 |
DKCM
3
Davidson Kempner Capital Management
New York
|
$6.96M |
4 |
AC
4
Athanor Capital
New York
|
$669K |
5 |
AAA
5
Affinity Asset Advisors
New York
|
$2.52M |